SCHEMBL3554284

SCHEMBL3554284

CC(=O)c1ccc(S(=O)(=O)Nc2ccc(CCc3ccc(C(=O)O)cc3)cc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.67
MEN1 O00255 3/20 0.67
KMT2A Q03164 3/20 0.67
HPGD P15428 3/20 0.67
LMNA P02545 3/20 0.67
SMN1; SMN2 Q16637 2/20 0.67
CA12 O43570 3/20 0.67
CA9 Q16790 3/20 0.67
MAPT P10636 3/20 0.65
CA1 P00915 2/20 0.61
CA2 P00918 2/20 0.61
ALOX12 P18054 1/20 0.58
GFER P55789 2/20 0.56
GAA P10253 2/20 0.54
POLB P06746 1/20 0.53
TP53 P04637 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3558523 0.89 CA1 (0.65) ALDH1A1MEN1KMT2AHPGDLMNA
SCHEMBL3554909 0.89 CA12 (0.60) ALDH1A1MEN1KMT2AHPGDLMNA
SCHEMBL3554401 0.89 CA12 (0.61) ALDH1A1MEN1KMT2AHPGDLMNA
SCHEMBL3556553 0.89 ALDH1A1 (0.73) ALDH1A1MEN1KMT2AHPGDLMNA
SCHEMBL3553771 0.87 CA12 (0.61) ALDH1A1MEN1KMT2AHPGDLMNA
SCHEMBL31681289 0.87 CA12 (0.62) ALDH1A1MEN1KMT2AHPGDLMNA
SCHEMBL3563796 0.87 HDAC1 (0.66) ALDH1A1MEN1KMT2ACA12CA9
SCHEMBL3558350 0.86 FFAR1 (0.67) ALDH1A1CA12CA9CA1CA2
SCHEMBL3558356 0.86 WDR5 (0.63) ALDH1A1MEN1KMT2ACA12CA9
SCHEMBL3560585 0.86 FFAR1 (0.63) ALDH1A1MEN1KMT2ALMNACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US claimed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US claimed
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US disclosed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes SLC5A1, ALDH7A1, ASS1 ALDH1A1 61/4885MEN1 2548/4885KMT2A 4045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.